March 8 (Mon) Room D

JPS Symposium
JPS symposium: A memorial symposium for Prof Burnstock -Pharmacology of purinergic signaling, past and future-
1-S03-19:0010:30
Overview for the study of P2 Receptors: From P2 Receptor History to Neuropathic Pain Studies
Kazuhide Inoue
The Institute for Advanced Study of Kyushu University
1-S03-29:0010:30
Adenosine A2A Receptor Antagonists for Parkinson’s Disease Treatment: 18 Years Adventure
Jiang-Fan Chen1,2
1Wenzhou Medical Univ, China, 2Boston Univ Sch Med, USA
1-S03-39:0010:30
Purine signaling complex - the birth and development of the concept
Fusao Kato
Dept Neurosci, Jikei Univ Sch Med
1-S03-49:0010:30
Dysfucntion of glial purinergic signals and depression
Schuichi Koizumi1
1Dept Neuropharmacol, Grad Sch Med, Univ Yamanashi, 2YiBIC
Symposium11
Cutting edge research on neurologic and psychiatric diseases focusing on targeted neurons and glial cells by applying a cell subtype-specific differentiation technique
1-S09-110:3012:00
Robust Platform of Neuronal Subtype-specific Differentiation Using Transcription Factors for in vitro Screening Applications
Mitsuru Ishikawa, Hideyuki Okano
Dept. Physiol. Keio Univ. Sch. Med.
1-S09-210:3012:00
Abnormalities of microglial differentiation in neuropsychiatric disorders: translational research using human blood-derived iMG cells
Takahiro A. Kato
Dept. Neuropsychiatry, Grad. Sch. Med. Sci. Kyushu Univ.
1-S09-310:3012:00
Modeling of psychiatric and neurodevelopmental disorders using iPSC technology
Takanobu Nakazawa
Dept Biosci, Tokyo Univ of Agr
1-S09-410:3012:00
Elucidation of the mechanisms of intractable neurologic diseases by applying techniques for the differentiation of iPS cells and reverse translational neuroscience research
Naoko Kuzumaki1, Yukari Suda1,2, Takahiro Kato3, Hideyuki Okano4, Minoru Narita1,2
1Dept. Pharmacol., Hoshi Univ., Tokyo, Japan, 2Div. Pathophysiol., Natl. Cancer Ctr. Res. Inst. Tokyo, Japan, 3Dept. Neuropsychiatry, Grad. Sch. Med. Sci., Kyushu Univ., Fukuoka, Japan, 4Dept. Physiol., Keio Univ. Sch. Med. Tokyo, Japan
Oral Sessions
Heart function, Heart failure (1)
1-O-D1-115:3015:42
Activation of YAP is essential for the myocardial recovery from myocarditis
Shoki Fukuyama1, Yusuke Kametani1, Yuriko Wada1, Shota Suzuki1, Ayaka Umeda1, Makiko Maeda2, Shota Tanaka1, Masanori Obana1, Yasushi Fujio1
1Laboratory of Clinical Science and Biomedicine., Grad. Sch. Pharm., Osaka Univ., 2Laboratory of Clinical Pharmacology and Therapeutics., Grad. Sch. Pharm., Osaka Univ.
1-O-D1-215:4215:54
Cardioprotective roles of novel cell death inhibitor, defender against cell death 1 (Dad1)
Shota Mori1, Shota Tanaka1, Makiko Maeda2, Masanori Obana1, Yasushi Fujio1,2
1Laboratory of Clinical Science and Biomedicine, Grad. Sch. Pharm., Osaka Univ., 2Laboratory of Clinical Pharmacology and Therapeutics, Grad. Sch. Pharm., Osaka Univ.
1-O-D1-315:5416:06
Regulation of fibrosis inhibitory factors by NOX1/NADPH oxidase in H9c2 cardiomyocytes
Kazumi Iwata, Chihiro Yabe-Nishimura
Dept. Pharmacol., Kyoto Pref. Univ. Med.
1-O-D1-416:0616:18
2,5-Dimethylcelecoxib attenuates cardiac remodeling after cryoinjury-induced myocardial infarction by suppressing the fibroblast-myofibroblast transformation
Ikushima Eigo1, Shin Ishikane1, Takehiro Kishigami1, Hiroaki Matsunaga1, Tomohiro Takiguchi2, Yumiko Toyohira1, Fumi Takahashi-Yanaga1
1Department of Pharmacology, School of Medicine, University of Occupational and Environmental Health, Japan., 2Department of Clinical Pharmacology, Graduate School of Medical Sciences, Kyushu University
Oral Sessions
Heart function, Heart failure (2)
1-O-D2-116:3016:42
Molecular mechanisms of Doxorubicin-induced cardiomyopathy, involvement in the impairment of mitophagy
Takeya Sato1, Mikio Muraoka1, Noriko Toda1,2, Guanjie Li1, Masanori Yamauchi2, Masaki Saito1, Teruyuki Yanagisawa1
1Dept. Mol. Pharm. Tohoku Univ. Grad.Sch. Med., 2Dept. Anesthesiol. Perioperat. Med. Tohoku Univ. Grad.Sch. Med
1-O-D2-216:4216:54
Induction of Autophagy Attenuates Imatinib-induced Cardiotoxicity
Miyuki Kobara, Hiroe Toba, Tetsuo Nakata
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
1-O-D2-316:5417:06
Oncocardiology of Anticancer Molecular Target Drugs
Kayoko Yamada1,2, Kyoko Yamamoto1,2, Yuka Mizutani1,2, Noriko Ichino1,2, Aoi Mori1,2, Yukiko Kato1,2, Yasuhito Shimada3, Yuhei Nishimura3, Toshio Tanaka1,2
1Department of Systems Pharmacology Mie University Graduate School of Medicine, 2Mie University Medical Zebrafish Research Center, 3Department of Integrative Pharmacology Mie University Graduate School of Medicine
1-O-D2-417:0617:18
Cancer cachexia-induced myocardial impairment could be improved by voluntary wheel running
Miki Nonaka1, Susumu Ueno2, Ryo Kakigi3, Nagomi Kurebayashi4, Takashi Murayama4, Kanako Miyano5, Kiyoshi Terawaki6, Takashi Sakurai4, Yasuhito Uezono1
1Dept. Pain Control Res., Jikei Univ. Sch. Med., 2Dept. Occup. Toxicol., Inst. Ind. Ecol. Sci., Univ. Occup. Environ. Hlth., 3Fac. Management & Information Sci, Josai International University, 4Dept. Pharmacol., Juntendo Univ. Sch. Med., 5Div. Pathophysiol., Natl. Cancer Ctr. Res. Inst., 6Tsumura Res. Labo., Tsumura & Co.
Oral Sessions
Arrhythmia, Channel
1-O-D3-117:3017:42
Effects of RyR2 specific inhibitors on arrhythmia in CPVT model mice
Nagomi Kurebayashi1, Takashi Murayama1, Koichiro Ishii1, Masato Konishi1, Masami Sugihara2, Shuichi Mori3, Hiroto Iinuma3, Mari Ishigami-Yuasa3, Nobuyuki Murakoshi4, Hiroyuki Kagechika3, Takashi Sakurai1
1Dept Cell Mol Pharmacol, Juntendo Univ Grad Sch Med, 2Dept Clin Lab Med, Juntendo Univ Gad Sch Med, 3IBB, Tokyo Med Dent Univ, 4Dept Cardiol, Fac Med, Univ Tsukuba
1-O-D3-217:4217:54
Cardiac safety pharmacological characteristics of class Id antiarrhythmic drug ranolazine in the halothane-anesthetized dog
Yoshio Nunoi1,2, Ryuichi Kambayashi1, Ai Goto1, Yoshiki Hirokawa1, Hiroko Izumi-Nakaseko1, Mihoko Hagiwara-Nagasawa1, Yoshinori Takei3, Akio Matsumoto4, Shinichi Kawai5, Yoshinori Watanabe2, Atsushi Sugiyama1,3,4,5
1Dept. Pharmacol., Faculty Med., Toho Univ., 2Div. Cardiovasc. Surg., Dept. Surg., Faculty Med, Toho Univ., 3Dept. Translational Research & Cellular Therapeutics, Faculty Med., Toho Univ., 4Dept. Aging Pharmacol., Faculty Med., Toho Univ., 5Dept. Inflammation & Pain Control Research, Faculty Med., Toho Univ.
1-O-D3-317:5418:06
Analysis of onset mechanisms on clinically reported, lamotrigine-induced cardiovascular adverse events as a reverse translational research using the halothane-anesthetized dogs
Ai Goto1, Yoshiki Hirokawa1, Yoshio Nunoi2, Ryuichi Kambayashi2, Hiroko Izumi-Nakaseko1,2, Mihoko Hagiwara-Nagasawa2, Akio Matsumoto3, Yoshinori Takei4, Shinichi Kawai5, Atsushi Sugiyama1,2,3,4,5
1Dept. Pharmacol., Grad. Sch. Med., Toho Univ., 2Dept. Pharmacol., Faculty. Med., Toho Univ., 3Dept. Aging Pharmacol., Faculty. Med., Toho Univ., 4Dept. Translational Research & Cellular Therapeutics., Faculty. Med., Toho Univ., 5Dept. Inflammation & Pain Control Research, Faculty. Med., Toho Univ.
1-O-D3-418:0618:18
Electropharmacological effects of licorice decoction on the heart: integral assessment using in vitro and in vivo models
Hiroko Izumi-Nakaseko1, Koki Chiba2, Ai Goto1, Ryuichi Kambayashi1, Yoshio Nunoi1, Mihoko Hagiwara-Nagasawa1, Akio Matsumoto3, Yoshinori Takei4, Shinichi Kawai5, Atsushi Sugiyama1,3,4,5
1Dept. Pharmacol., Faculty. Med., Toho Univ., 2Dept. Trad. Med., Faculty Med., Toho Univ., 3Dept. Translational Research & Cellular Therapeutics, Faculty Med., Toho Univ., 4Dept. Aging Pharmacol., Faculty Med., Toho Univ., 5Dept. Inflammation & Pain Control Research, Faculty Med., Toho Univ.
1-O-D3-518:1818:30
Nardilysin controls heart rate through the transcriptional regulation of ion channels critical for sinus automaticity.
Mikiko Ohno1, Hiroshi Matsuura2, Takeru Makiyama3, Yasuhiko Koujitani3, Kiyoto Nishi3, Hirotaka Iwasaki1, Shintaro Matsuda3, Takeshi Kimura3, Eiichiro Nishi1
1Dept. Pharm. Shiga Univ. Med. Sci., 2Dept. Phisio. Shiga Univ. Med. Sci., 3Dept. Cardiovasc. Med, Grad. Sch. Med., Kyoto Univ.
pagetop